Cargando…
Improving the Antitumor Effect of Chemotherapy with Ocoxin as a Novel Adjuvant Agent to Treat Prostate Cancer
Prostate cancer is one of the most common cancers among men. Although many patients respond favorably to first-line treatments, castration—and chemotherapy—resistance arises after a few years, leading to metastasis. Thus, new approaches are being investigated using natural supplements to reinforce c...
Autores principales: | Hernandez-Unzueta, Iera, Benedicto, Aitor, Telleria, Uxue, Sanz, Eduardo, Márquez, Joana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10255289/ https://www.ncbi.nlm.nih.gov/pubmed/37299500 http://dx.doi.org/10.3390/nu15112536 |
Ejemplares similares
-
Ocoxin Increases the Antitumor Effect of BRAF Inhibition and Reduces Cancer Associated Fibroblast-Mediated Chemoresistance and Protumoral Activity in Metastatic Melanoma
por: Benedicto, Aitor, et al.
Publicado: (2021) -
Ocoxin Oral Solution Exerts an Antitumoral Effect in Pancreatic Cancer and Reduces the Stromal-Mediated Chemoresistance
por: Hernandez-Unzueta, Iera, et al.
Publicado: (2019) -
Ocoxin oral solution(®) as a complement to irinotecan chemotherapy in the metastatic progression of colorectal cancer to the liver
por: Hernandez-Unzueta, Iera, et al.
Publicado: (2017) -
Ocoxin(®) oral solution slows down tumor growth in an experimental model of colorectal cancer metastasis to the liver in Balb/c mice
por: MÁRQUEZ, JOANA, et al.
Publicado: (2016) -
Ocoxin as a complement to first line treatments in cancer
por: Benedicto, Aitor, et al.
Publicado: (2021)